AzTrials
AzTrials

Neonatal HyperbilirubinemiaNEO-BATHNCT07084987

Massage, Tub Bathing, and Sponge Bathing Effects on Neonatal Bilirubin and Comfort

A study testing neonatal massage, Tub Bathing and sponge bath in people with Neonatal Hyperbilirubinemia and Newborn Care Phototherapy, run by Uludag University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial evaluates the effects of massage, tub bathing, and sponge bathing on bilirubin levels, skin integrity, neonatal comfort, and physiological parameters in term newborns undergoing phototherapy Read more about this study

Who is it for?
Ages 1 day to 28 days
What is being tested?
neonatal massage, Tub Bathing and sponge bath
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Sep 2021to 1 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Receiving phototherapy
  • Stable vital signs
  • Parental consent

Who cannot join

  • Congenital anomalies
  • Severe infections or sepsis
  • Parental refusal

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bandırma Education and Research Hospital

    Bandırma, Balıkesir, 10200

Other trials in Turkey (Türkiye)

About this study

Official title: Effects of Massage, Tub Bathing, and Sponge Bathing on Bilirubin Levels, Skin Barrier, Neonatal Comfort, and Vital Signs: A Randomized Clinical Trial

This randomized controlled trial evaluates the effects of massage, tub bathing, and sponge bathing on bilirubin levels, skin integrity, neonatal comfort, and physiological parameters in term newborns undergoing phototherapy

Read the detailed description

Term newborns undergoing phototherapy in the neonatal intensive care unit will be randomized into four groups: massage, sponge bath, tub bath, and control. Pre-intervention assessments include vital signs, skin moisture, bilirubin levels, the Neonatal Comfort Behavior Scale, and the Skin Condition Assessment Scale. Post-intervention assessments are conducted at multiple time points. The study investigates whether massage and bathing interventions can improve comfort, maintain skin integrity, and reduce bilirubin levels more effectively than standard care.

Being tested
neonatal massage, Tub Bathing, sponge bath
Keywords
Neonatal Hyperbilirubinemia, Phototherapy, Neonatal Massage
Medical subject headings
Hyperbilirubinemia, Neonatal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neonatal massageOther

    Standardized neonatal massage before phototherapy

  • Tub BathingOther

    Tub bath before phototherapy

  • sponge bathOther

    Sponge (wipe) bath before phototherapy

Study groups in NCT07084987
Study groupRoleWhat they receive
massage groupExperimentalNewborns receive standardized neonatal massages before phototherapy.
Receives: Other: neonatal massage
Tub Bath GroupExperimentalNewborns receive a warm water tub bath prior to phototherapy.
Receives: Other: Tub Bathing
Sponge Bath GroupExperimentalNewborns receive a sponge (wipe) bath before phototherapy.
Receives: Other: sponge bath
Control GroupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Serum Bilirubin Levels

    Measured in mg/dL using standard laboratory testing

    Measured: Baseline, 6 hours, 24 hours after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2025
  2. Study start1 Sep 2021
  3. Primary completion1 Jan 2023
  4. Study completion1 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomly assigned to one of four parallel groups: massage, tub bath, sponge bath, or control.
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07084987
Sponsor's protocol ID
RUKİYEOZTURK-2025
Other IDs
2021-42
Acronym
NEO-BATH
Status last verified
Jul 2025
First submitted
9 Jul 2025
Last updated
25 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be shared to protect participant privacy and confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing neonatal massage, Tub Bathing and sponge bath in people with Neonatal Hyperbilirubinemia and Newborn Care Phototherapy, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Serum Bilirubin Levels (time frame: Baseline, 6 hours, 24 hours after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in